title: [Progestogen contraception using chlormadinone acetate in women presenting high vascular risk. (A gynecoendocrine, metabolic and vascular study)].
authors.forename: C
authors.initials: C
authors.lastname: Pelissier
authors.forename: A
authors.initials: A
authors.lastname: Basdevant
authors.forename: J
authors.initials: J
authors.lastname: Conard
authors.forename: M
authors.initials: M
authors.lastname: Egloff
authors.forename: T
authors.initials: T
authors.lastname: Husson
authors.forename: T T
authors.initials: TT
authors.lastname: Guyenne
mesh_terms: D001695:Biology; D002319:Cardiovascular System; D002715:Chlormadinone Acetate; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003278:Contraceptives, Oral, Hormonal; D019049:Developed Countries; D004194:Disease; D004467:Economics; D004703:Endocrine System; D005060:Europe; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D005602:France; D006728:Hormones; D008660:Metabolism; D010827:Physiology; D012102:Reproductive Control Agents; D012106:Research; D013672:Technology
chemical_list: D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003278:Contraceptives, Oral, Hormonal; D006728:Hormones; D012102:Reproductive Control Agents; D002715:Chlormadinone Acetate
keywords: Biology; Cardiovascular Effects; Chlormadinone Acetate; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen--contraindications; Contraceptive Agents, Female; Contraceptive Agents, Progestin--indications; Contraceptive Agents--contraindications; Contraceptive Agents--indications; Developed Countries; Diseases; Economic Factors; Endocrine System; Europe; Evaluation; Family Planning; France; Hormones; Mediterranean Countries; Metabolic Effects; Physiology; Reproductive Control Agents; Research And Development; Research Methodology; Reversibility; Technology; Western Europe